Objectives of the meeting

The aim of this meeting is to provide a state-of-play of the promises, existing gaps and future challenges of global approaches that tackle emerging and re-emerging infectious diseases, with a particular focus on human and veterinary vaccines. Many trans-sectorial and multidisciplinary issues dealing with vaccine development, field impact assessment, partnerships and networking, and pharmaco-economical studies will be presented and discussed through plenary talks and roundtables involving high profile stakeholders from academia, industry, governmental and non-governmental organizations

Scientific Committee

  • Marc Bonneville (Institut Mérieux, Lyon, France)
  • Marie-Paule Kieny (Inserm, Paris, France)
  • Rick Hill (IABS, Ames, Iowa)
  • Paul Henri Lambert (University of Geneva, Switzerland)
  • Michel Goldman (I3H Institute, Université Libre de Bruxelles, Belgique)
  • Christine Delprat (Université Lyon 1, Lyon, France)
  • Nathalie Garçon (BIOASTER, Lyon, France)
  • Pieter Neels (IABS, Belgium)
  • Jean-Christophe Audonnet (Boehringer Ingelheim, Lyon, France)
  • Laurent Mallet (EDQM, Strabourg, France)
  • Penny HEATON (Gates Medical Research Institute, U.S.A.)